The unrestricted funding of the MGH Research Scholars program empowers scientists to meet the challenges of the COVID-19 pandemic.
Infectious disease experts identify key components – many related to testing – when considering the successful reopening of the country, following COVID-19.
Under the leadership of Keith Flaherty, MD, clinical researchers at Mass General are teaming up to fight the COVID-19 pandemic.
Senior Vice President for Research Harry Orf, PhD, describes how Mass General researchers are responding to the COVID-19 epidemic.
The new Mass General Brigham Center for COVID Innovation is racing against the clock to put protective equipment, tests, ventilators and information into the hands of frontline health care workers.
Mass General brain imaging researcher Yakeel T. Quiroz, PhD, identified a rare gene that may provide protection from Alzheimer’s disease.
Mass General researchers have uncovered a novel potential antiviral drug target that could lead to treatments protecting against a host of infectious diseases – creating a universal treatment.
Researchers have created math models that can predict how tumors may respond to immunotherapy and how adding other anti-cancer drugs could lead to improved treatment.
Addressing one of the greatest challenges of modern cancer treatment, Russell Jenkins, MD, PhD, is working to predict who will respond to immunotherapy treatment.
Using single-celled yeast, a trailblazing researcher at the Mass General Cancer Center has developed a way to lure dormant cancer cells out of hiding so cancer therapy can do its work.